carrageenan

Botanicalexperimental

The Population Council is an international, nonprofit, non-governmental organization. The Council conducts research in biomedicine, social science, and public health and helps build research capacities in developing countries. One-third of its research relates to HIV and AIDS; while its other major program areas are still linked to its early foundation in reproductive health and its relation to poverty, youth, and gender. For example, the Population Council strives to teach boys that they can be involved in contraceptive methods regardless of stereotypes that limit male responsibility in child bearing. The organization held the license for Norplant contraceptive implant, and now holds the license for Mirena intrauterine system. The Population Council also publishes the journal Population and Development Review, which reports scientific research on the interrelationships between population and socioeconomic development. It also provides a forum for discussion on related issues of public policy and Studies in Family Planning, which focuses on public health, social science, and biomedical research involving sexual and reproductive health, fertility, and family planning. — Wikipedia

Clinical trial activity

15 trials · 30 clinical orgs · 0 marketing orgs

Phase 1
4
Phase 2
6
Phase 3
2
Phase 4
3

Earliest trial started Oct 1, 1999 (NCT00213018)

Timeline

1990s

  1. Jan 1, 1999

    Earliest Phase 2 Sponsor(trial)

2000s

  1. Jan 1, 2001

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2004

    Earliest Phase 3 Sponsor(trial)

Indications

Approved for

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • carrageenan
  • carrageenan
  • carrageenan
  • carraghenates
  • carraguard
  • marine colloids

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05049213Phase 4Sep 20, 2021National Taiwan University
NCT04701710Phase 1/Phase 2 (Phase 2)Oct 15, 2020Government of Argentina
NCT04521322Phase 4Jul 24, 2020Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno
NCT03118583N/AMar 15, 2017MB Clinical Research and Consulting LLC, Midwest Center for Metabolic and Cardiovascular Research
NCT03009799Phase 2Jan 1, 2017Iris Pharma, NicOx, Theradis pharma
NCT02354144Phase 2/Phase 3 (Phase 3)Feb 29, 2016McGill University, University of Montreal
NCT02629705N/AOct 1, 2015University of Tuebingen
NCT02382419Phase 2Aug 1, 2014National Cancer Institute (NCI), Yeshiva University
NCT01881282Phase 4Dec 1, 2006Johnson and Johnson
NCT00213083Phase 3Apr 1, 2004Bill and Melinda Gates Foundation, Population Council, United States Agency for International Development
NCT00213044Phase 1Mar 1, 2003Centers for Disease Control and Prevention (CDC), Chiang Rai District Health Office, Chiangrai Prachanukroh Hospital, Government of Thailand, National Center for HIV STD and TB Prevention, National Center for Infectious Diseases, Population Council
NCT00213005Phase 1Jun 1, 2002Centers for Disease Control and Prevention (CDC), International Antiviral Therapy Evaluation Center (IATEC), Medical Research Council, Population Council
NCT00213057Phase 1Jun 1, 2001Bill and Melinda Gates Foundation, Centers for Disease Control and Prevention (CDC), Chiang Rai District Health Office, Chiangrai Prachanukroh Hospital, Government of Thailand, Population Council
NCT00213031Phase 2Feb 1, 2000Bill and Melinda Gates Foundation, Centers for Disease Control and Prevention (CDC), Chiang Rai District Health Office, Chiangrai Prachanukroh Hospital, Government of Thailand, National Center for Infectious Diseases, Population Council
NCT00213018Phase 2Oct 1, 1999Bill and Melinda Gates Foundation, FHI 360, Medical Research Council, South Africa, National Institute of Allergy and Infectious Diseases (NIAID), Population Council, United States Agency for International Development, University of Cape Town, University of Limpopo
Showing 15 of 15 trials
Page 1 / 1

Organizations

Research & Development (30)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Population CouncilAcademic/Hospital6631999
Bill and Melinda Gates FoundationAcademic/Hospital4031999
Centers for Disease Control and Prevention (CDC)Government4022000
Chiang Rai District Health OfficeGovernment3022000
Chiangrai Prachanukroh HospitalAcademic/Hospital3022000
Government of ThailandGovernment3022000
National Center for Infectious DiseasesGovernment2022000
United States Agency for International DevelopmentGovernment2021999
Centro de Educación Medica e Investigaciones Clínicas Norberto QuirnoAcademic/Hospital1112020
FHI 360Academic/Hospital1011999
Government of ArgentinaGovernment1112020
International Antiviral Therapy Evaluation Center (IATEC)Academic/Hospital1012002
Iris PharmaFor profit1012017
Johnson and JohnsonFor profit1112006
MB Clinical Research and Consulting LLCFor profit1012017
McGill UniversityAcademic/Hospital1112016
Medical Research CouncilGovernment1012002
Medical Research Council, South AfricaGovernment1011999
Midwest Center for Metabolic and Cardiovascular ResearchAcademic/Hospital1112017
National Cancer Institute (NCI)Government1012014
30 organizations
Page 1 / 2